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Abstract 
Research on major depression has confirmed that it is caused by an array of biopsychosocial and 
lifestyle factors. Diet, exercise and sleep are three such influences that play a significant 
mediating role in the development, progression and treatment of this condition. This review 
summarises animal and human-based studies on the relationship between these three lifestyle 
factors and major depressive disorder, and their influence on dysregulated pathways associated 
with depression, namely neurotransmitter processes, immuno-inflammatory pathways, 
hypothalamic-pituitary-adrenal (HPA) axis disturbances, oxidative stress and antioxidant 
defence systems, neuroprogression, and mitochondrial disturbances. Increased attention in 
future clinical studies on the influence of diet, sleep and exercise on major depressive disorder 
and investigations of their effect on physiological processes will help to expand our 
understanding and treatment of major depressive disorder. Mental health interventions, taking 
into account the bidirectional relationship between these lifestyle factors and major depression 
are also likely to enhance the efficacy of interventions associated with this disorder. 
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1. Introduction 
Technological advances have changed how we communicate, the activities we engage in, our 
occupational and recreational pursuits, and even the foods that we eat. While sport and leisure 
activity levels have remained stable or increased slightly over time, physical activity associated 
with work, home, and transportation has declined significantly (Brownson et al., 2005, Juneau 
and Potvin, 2010). In the United States it was estimated that over the past 50 years occupation-
related energy expenditure decreased by more than 100 calories/day (Church et al., 2011). 
Driving to work increased from 67% of the working north American population in 1960 to 88% in 
2000 (Brownson et al., 2005) and, in U.S. schoolchildren, walking or riding bikes to school 
decreased from 40% in 1969 to 13% in 2001 (McDonald, 2007).  Dietary changes are also 
significant as worldwide sugar consumption has increased by 74-kcal/day per person from 1962 
to 2000. Of this increase, 80% was derived from sugared beverages with additional contributions 
from restaurant and fast food sources (Popkin and Nielsen, 2003). Alarmingly, sugar 
consumption has increased most in children aged 6-11 years with an approximate 20% increase 
from 1988 to 2004 (Wang et al., 2008).  
These and other changes of modernity over the past few decades have coincided with a reported 
increase in the prevalence of many psychiatric problems, including major depression. Between 
1991-92 to 2001-2, one-year prevalence rates of major depression increased from 3.33% to 7.06% in 
a community population of American adults (Compton et al., 2006). Increases have also been 
observed in Australian communities with prevalence rates rising from 6.8% to 10.3% between 
1998 and 2008 (Goldney et al., 2010). While these increased rates of depression may be due, in 
part, to improvements in diagnostic recognition, changes in diagnostic criteria and increased 
community acceptance of this condition, contemporary lifestyles might also explain why 
depression is on the rise. However, underlying mechanisms are not well understood. This review 
provides a summary of three major lifestyle mediators - diet, exercise and sleep - associated with 
major depression and their impact on a range of relevant biological and physiological pathways.   
 
2. Methods 
2.1. Search strategy 
The PubMed, Google Scholar, and PsycInfo databases were searched from all years of record 
until August 2012. Most references were obtained from combinations of the following key terms: 
“depression”, “diet”, “nutrients”, “sleep”, “exercise”, “inflammation”, “oxidative stress”, 
“mitochondria”, “neurogenesis”, “BDNF”, “HPA”, “cortisol”, “serotonin” and “monoamines”. 
The reference lists of relevant papers were also examined to locate additional studies that were 
not identified by the database searches.  
2.2. Eligibility criteria 
Studies were included in this review if they were published in English, comprised animal or 
human investigations and examined areas of exercise, sleep or diet and their impact either on 
inflammation, hypothalamic–pituitary–adrenal (HPA) axis, neurotransmitters, neuroprogression 
and oxidative/nitrosative stress.  
3. Dysregulated pathways in major depression 
Major depression has a multifactorial etiology arising from environmental, psychological, genetic 
and biological factors. As outlined in figure 1, research over the past decade has clarified that 
depression is associated with neurotransmitter imbalances, HPA disturbances, dysregulated 
inflammatory pathways, increased oxidative and nitrosative damage, neuroprogression, and 
mitochondrial disturbances (Leonard and Maes, 2012, Lopresti et al., 2012, Maes et al., 2009c, 
Manji et al., 2001, Raison and Miller, 2011). While these disturbances will each be discussed 
briefly they are not mutually exclusive. 
 
<<<insert Figure 1 near here> 
 
3.1. Neurotransmitter imbalances 
Imbalances in the production and transmission of neurotransmitters such as serotonin, 
dopamine, noradrenaline and glutamate are commonly observed in the central nervous system in 
major depression (Maletic et al., 2007). Deficiencies in serotonin availability, the most extensively 
studied neurotransmitter in depression, is supported by studies using tryptophan depletion 
models (which reduces central serotonin synthesis) (Hood et al., 2005, Toker et al., 2010) and 
findings of serotonin receptor abnormalities in depressed patients (Carr and Lucki, 2011). 
Depression is also associated with an increased availability of monoamine oxidase, an enzyme 
that metabolises serotonin and other monoamines in the brain (Meyer et al., 2006), and 
abnormalities in the expression of the enzyme tryptophan hydroxylase, which is involved in 
serotonin synthesis (Matthes et al., 2010). However, the strongest evidence of neurotransmitter 
imbalances in depression comes from the popular use and efficacy of pharmaceutical 
antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), which are thought to 
alleviate depression by increasing the availability of monoamines such as serotonin, 
noradrenaline (i.e., norepinephrine) and, possibly, dopamine (Connolly and Thase, 2012).   
 
3.2. HPA disturbances 
Dysfunction in the HPA axis is common in patients with major depression (Pariante and 
Lightman, 2008). This is characterised by heightened cortisol secretion in patients presenting with 
melancholic depression, and reduced levels in atypical depression (Gold and Chrousos, 2002). 
Depression is also associated with hypersecretion of corticotropin-releasing hormone (CRH) and 
impairment in responsiveness to glucocorticoids (Pariante and Lightman, 2008). An increased 
size and activity of the pituitary and adrenal glands are also found in major depression 
(Nemeroff et al., 1992). Successful treatment with antidepressants is associated with a 
normalisation of HPA axis activity and restoration in glucocorticoid receptor function (Anacker 
et al., 2011a, Anacker et al., 2011b). 
3.3. Oxidative & nitrosative stress 
Decreased antioxidant status and elevated oxidative and nitrosative stress are found in patients 
with major depression (Maes et al., 2011a). This is evidenced by reduced plasma concentrations 
of important antioxidants such as vitamin C (Khanzode et al., 2003), vitamin E (Maes et al., 2000, 
Owen et al., 2005), and coenzyme Q10 (Maes et al., 2009b),  and by reduced antioxidant enzyme 
activity such as glutathione peroxidase (Maes et al., 2011d). These deficiencies in antioxidant 
defences impair protection against reactive oxygen species (ROS), leading to damage to fatty 
acids, proteins and DNA (Maes et al., 2011a).  
Depression is also associated with increased levels of lipid peroxidation, comprising elevations in 
malondialdehyde (Ozcan et al., 2004, Sarandol et al., 2007, Wei et al., 2009), and increased 
oxidative damage to DNA, characterised by increased levels of 8-hydroxy-2-deoxyguanosine  
(Forlenza and Miller, 2006, Maes et al., 2009a). Depression is also associated with increased 
plasma levels of peroxides and xanthine oxidase (Herken et al., 2007, Maes et al., 2010). The 
efficacy of antioxidant therapies for depression is unknown, although N-acetylcysteine, a 
powerful antioxidant, was found to be useful for depressive episodes in bipolar disorder (Berk et 
al., 2008, Magalhaes et al., 2011) and zinc, which serves as a strong antioxidant, also has 
antidepressant activity (Szewczyk et al., 2011). 
3.4. Neuroprogression 
Neurogenesis and neuronal plasticity are compromised in major depression, with subsequent 
neurodegeneration (Lee and Kim, 2010). This results in stress-induced alterations to the number 
and shape of neurons and glia in brain regions of depressed patients (Duman, 2009) and 
decreased proliferation of neural stem cells (Eyre and Baune, 2012).  
Brain-derived neurotrophic factor (BDNF) is the most abundant and widely distributed 
neurotrophin in the central nervous system, involved in neuronal survival, growth and 
proliferation (Martinowich and Lu, 2008). BDNF levels are low in people with major depression 
(Duman, 2009, Lee and Kim, 2010). However, BDNF levels increase with chronic administration 
of several classes of antidepressants, including monoamine oxidase inhibitors, SSRIs, tricyclic 
agents, and SNRIs (Duman and Monteggia, 2006, Sen et al., 2008).  Early life and chronic stress, 
which is often typical in patients with major depression, also has detrimental effects on BDNF 
(Martinowich et al., 2007, Nagahara and Tuszynski, 2011).  
 
3.5. Mitochondrial disturbances 
Mitochondria are intracellular organelles that generate most of the cell's supply of adenosine 
triphosphate (ATP) and are also involved in a range of other processes such as signalling, cellular 
differentiation, cell death, and the control of the cell cycle and cell growth (McBride et al., 2006). 
High concentrations of mitochondria are found in the brain which increases its vulnerability to 
reductions in aerobic metabolism (Pieczenik and Neustadt, 2007). 
Depression is associated with mitochondrial dysfunction or disease with evidence of deletions of 
mitochondrial DNA (Gardner and Boles, 2008a, Shao et al., 2008), and lower activities of 
respiratory chain enzymes and ATP production (Gardner et al., 2003). Depressed patients 
presenting with somatic complaints also have low ATP production rates in biopsied muscles 
(Gardner and Boles, 2008a, Gardner and Boles, 2008b). In addition, rates of depression are 
increased in patients with mitochondrial disorders (Fattal et al., 2007, Koene et al., 2009). 
3.6. Immuno-inflammation 
Increased inflammation in major depression has been confirmed in three recent meta-analyses. 
Elevated levels of C-reactive protein (CRP), interleukin-1 (IL-1), and interleukin-6 (IL-6) were 
reported in a meta-analysis on depression in clinic and community samples (Howren et al., 2009), 
levels of tumour necrosis factor-α (TNF-α) and IL-6 were significantly higher in depressed 
patients than controls (Dowlati et al., 2010), and  blood levels of soluble interleukin-2 receptors, 
TNF-α and IL-6 were higher in a meta-analysis on patients with major depressive disorder than 
controls (Liu et al., 2012b). Major depression is also characterised by a Th-1-like cell-mediated 
response, with evidence of increased production of interferon-γ (IFN-γ), increased IFN-γ/IL-4 
ratios and increased neopterin levels (Maes et al., 1994, Myint et al., 2005). In addition, anti-
depressant medications have anti-inflammatory effects (Hannestad et al., 2011).  
An elevated immuno-inflammatory response in major depression is further supported by 
investigations into kynurenine pathway metabolites or TRYCATS (tryptophan catabolites along 
the IDO pathway) (Dantzer et al., 2011, Maes et al., 2011c). As shown in Figure 2, TRYCATS are 
produced by the breakdown of tryptophan, involving the enzyme indoleamine 2,3-dioxygenase 
(IDO). IDO is expressed in multiple cell types including macrophages, dendritic cells, astrocytes 
and microglia and is strongly activated by the pro-inflammatory cytokine IFN-γ and to a lesser 
extent TNF-α, IL-1, and IL-6. These TRYCATS have both neurotoxic and neuroprotective 
qualities. Preliminary research has demonstrated a relationship between depression and low 
levels of the neuroprotective TRYCAT, kynurenic acid (KYNA) (Maes et al., 2011b, Myint et al., 
2007, Wichers et al., 2005), and high levels of the excitotoxic TRYCAT, quinolinic acid (QUIN) 
(Raison et al., 2010a, Steiner et al., 2011). However, further research is warranted as Hughes et al., 
(2012) found no differences in IDO expression or plasma levels of TRYCATS between depressed 
patients and controls. 
<<<insert Figure 2 near here> 
4. Lifestyle factors associated with major depression 
Dysregulation in the pathways reviewed above can be influenced by environmental, social, 
psychological, lifestyle, genetic and physiological factors (Hidaka, 2012, Leonard and Maes, 
2012). Diet, sleep and exercise are three such influences that play an important role in the  
 
etiology, progression and treatment of depression. A bidirectional relationship likely exists 
between depression and these mediators. 
4.1. The relationship between diet and depression  
An association between diet and depression has now been confirmed in prospective and 
epidemiological studies. For example, in elderly men and women, the consumption of fish, 
vegetables, olive oil, and cereal correlated negatively with the severity of depressive symptoms 
(Mamplekou et al., 2010). The benefits from fish and olive oil intake remained significant even 
when adjusted for confounders such as age, sex, education status, BMI and physical activity 
status, as well as the presence of a number of medical conditions. In a prospective study, and 
after adjusting for sex, age, smoking status, BMI, physical activity levels and employment status, 
adherence to a Mediterranean diet comprising high levels of vegetables, fruit, nuts, cereal, 
legumes, and fish, a moderate alcohol intake, and a low consumption of meat or meat products 
and whole-fat dairy, was protective against the development of depression (Sanchez-Villegas et 
al., 2009). In a study by Jacka et al. (2010b), consuming a ‘traditional’ diet comprising vegetables, 
fruit, meat, fish, and whole grains was also associated with a 35% reduced risk of depression or 
dysthymia. Research into the diet of adolescents (Jacka et al., 2010a) and of low socio-economic, 
community dwelling, elderly people (German et al., 2011) has also provided evidence for an 
association between diet quality and depression. Depressive symptoms are also positively 
associated with the consumption of sweets (Jeffery et al., 2009). Similarly, high intake of fast food 
(hamburgers, sausages, pizza) and processed pastries (muffins, doughnuts, croissants) are 
associated with an increased risk of depression up to 6 years later (Sanchez-Villegas et al., 2012). 
High-quality treatment studies investigating the impact of diet on depression are scarce, 
although in a randomised-controlled trial, meat-eating adults placed on a two-week vegetarian 
diet reported significantly greater improvements in mood compared to participants who 
continued to eat meat, fish or poultry (Beezhold and Johnston, 2012). In another randomised-
controlled trial, six days on a low protein diet significantly decreased depressive symptoms in 
type 2 diabetics (Ciarambino et al., 2011), and in a randomised study on overweight and obese 
individuals, those placed on an energy-restricted, low-fat diet for one year experienced greater 
improvements in mood compared to participants on an energy-restricted, low-carbohydrate diet 
(Brinkworth et al., 2009). These changes were independent of weight loss.  
Polyunsaturated fatty acids (PUFAs) and particularly omega-3 essential fatty acids (ω-3 EFA) 
have received significant attention in relation to depression. In a meta-analysis of 14 studies 
comparing the levels of PUFAs between depressed patients and control subjects, the levels of 
eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and total ω-3 EFA were significantly 
lower in depressed patients than controls (corresponding to effect sizes of -0.18, -0.35 and -0.51, 
respectively). There was no significant change in arachidonic acid (AA) or total ω-6 PUFAs (Lin 
et al., 2010). A meta-analysis of the effects of EPA supplementation in 15 clinical trials in 
depressed populations revealed beneficial effects from fish oil containing high levels of EPA 
(effect size = 0.53) (Sublette et al., 2011).  
Other investigations on the relationship between nutrients and depression have demonstrated a 
role of folate (Farah, 2009, Gilbody et al., 2007, Morris et al., 2008), tryptophan (Cowen et al., 1989, 
DeMyer et al., 1981, Maes et al., 1987), zinc (Cope and Levenson, 2010, Lai et al., 2012, Szewczyk 
et al., 2011), iron (Maes et al., 1996, Stewart and Hirani, 2012, Vahdat Shariatpanaahi et al., 2007, 
Yi et al., 2011), CoQ10 (Maes et al., 2009b), vitamin B6 (Merete et al., 2008, Moorthy et al., 2012, 
Skarupski et al., 2010, Williams et al., 2005), vitamin B12 (Hintikka et al., 2003, Moorthy et al.,  
 
2012), and selenium (Gao et al., 2012, Mokhber et al., 2011, Pasco et al., 2012). However, findings 
on most of these nutrients require further investigation before definitive conclusions about their 
relationship with depression can be made. 
4.1.1. Diet and its effect on inflammation 
There is now strong evidence in human studies that adherence to a Mediterranean diet is 
associated with reduced inflammatory markers (Camargo et al., 2012, Richard et al., 2012, Urpi-
Sarda et al., 2012). In a study on people with metabolic syndrome, five weeks on a Mediterranean 
diet corresponded with lowered plasma CRP and an arbitrary inflammatory score that included 
CRP, IL-6, IL-18, and TNF-α. These changes were independent of any weight loss (Richard et al., 
2012). Compared to participants placed on a low-fat diet, one year on a Mediterranean diet was 
associated with lowered plasma concentrations of IL-6, and two TNF receptors (Urpi-Sarda et al., 
2012). In contrast, intercellular adhesion molecule-1 and TNF receptor concentrations were 
increased in people consuming a low-fat diet. In another intervention study, postprandial 
inflammatory gene expression in mononuclear cells decreased after three weeks on either a 
Mediterranean diet enriched with olive oil, a diet rich in saturated fatty acids, or a low-fat/high-
carbohydrate diet enriched with ω-3 PUFU compared to the other diets (Camargo et al., 2012, 
Yubero-Serrano et al., 2012)). Luciano and colleagues (2012) also found that CRP levels were 
lower in an elderly population on a Mediterranean diet compared to a standard ‘healthy diet’ 
comprising a high intake of fruits and low consumption of eggs, spirits or liqueurs, and meats 
such as bacon, pork, lamb, and sausages . 
In relation to the anti-inflammatory effect of PUFAs, in a recent review of twenty-six randomised 
clinical trials, dietary ω-3 EFAs were found to be associated with lower plasma biomarker levels, 
reflecting lower levels of inflammation and endothelial activation (e.g., IL-6, CRP, TNF- α, 
sICAM-1 and GM-CSF) in cardiovascular disease and other chronic and acute diseases. Calder 
(2012) recently concluded that fatty acids were able to partly inhibit a number of aspects of 
inflammation including leukocyte chemotaxis, adhesion molecule expression and leukocyte-
endothelial adhesive interactions, production of eicosanoids from arachidonic acid, production of 
inflammatory cytokines, and T cell reactivity. 
4.1.2. Diet and its effect on neurotransmitters 
Diet quality is important in the production of monoamines such as serotonin and dopamine and 
can influence receptor sensitivity and neurotransmitter transporters. In animal studies, semi-
starvation on a high carbohydrate or protein diet affected serotonin turnover in the brain 
(Schweiger et al., 1989). In addition, the consumption of sugar as part of a meal (Inam et al., 2006) 
or eating a high-carbohydrate diet (Buwalda et al., 2001) influenced 5-HT1A receptor sensitivity; 
and one week on a high fat, low carbohydrate diet decreased serotonin release in the 
hypothalamus (Banas et al., 2009). In contrast, the acute intake of a carbohydrate-rich food 
increased brain tryptophan and consequent brain serotonin levels (Fernstrom and Wurtman, 
1971). This was likely due to carbohydrates acutely increasing brain tryptophan availability 
compared to other large neutral amino acids (Wurtman and Wurtman, 1995).   
Dopaminergic systems are also influenced by diet as the consumption of combinations of dietary 
fat and sugar reduced D2 receptor signalling (Pritchett and Hajnal, 2011), the intake of a high fat 
diet altered dopamine-related gene expression (Lee et al., 2010, Vucetic et al., 2012), a high-fat 
diet during early life altered biochemical markers of dopamine signalling in the nucleus 
accumbens  (Teegarden et al., 2009), and the long-term consumption of a low protein-high  
 
carbohydrate diet decreased D2 dopamine receptor density (Hamdi et al., 1992). Striatal 
dopamine levels were also increased in rats supplemented with strawberry, spinach, or vitamin E 
(Martin et al., 2000).  
Other nutrients which are altered in patients with major depression and that can influence 
neurotransmitter production include tryptophan (and other large neutral amino acids: valine, 
leucine, isoleucine, phenylalanine and tyrosine) (Maes et al., 2011c, Markus, 2008, Toker et al., 
2010), folic acid (Miller, 2008, Stahl, 2008), zinc (Cichy et al., 2009, Szewczyk et al., 2011, Szewczyk 
et al., 2009), vitamin B12 (Bottiglieri, 1996, Deana et al., 1977), vitamin B6 (Calderon-Guzman et 
al., 2004, Demisch and Kaczmarczyk, 1991, Hartvig et al., 1995) and iron (Baumgartner et al., 
2012, Burhans et al., 2005, Coe et al., 2009). Omega-3 EFAs are also able to modify monoaminergic 
neurotransmission (Chalon, 2006, Su, 2009). 
4.1.3. Diet and its effect on oxidative stress 
Given the crucial role that diet plays in antioxidant intake, it comes as no surprise that diet 
quality influences levels of oxidative stress. In animal studies, rats fed a high-sugar/high-fat diet 
had increased lipid peroxidation in the brain (Ribeiro et al., 2009, Stranahan et al., 2011), elevated 
plasma malondialdehyde (MDA) concentrations (a marker of lipid peroxidation) (Panchal et al., 
2011) and increased mRNA expression levels of genes involved in ROS production in both the 
liver and adipose tissue (Matsuzawa-Nagata et al., 2008). In obese adults with metabolic 
syndrome, reducing energy intake by 2000kJ, mainly via carbohydrate restriction, was associated 
with decreased oxidative stress and increased levels of antioxidant markers, alpha-tocopherol 
and ceruloplasmin (Skalicky et al., 2009).  However, placing adults with metabolic syndrome on a 
12-week high-fat diet or low-fat, high complex-carbohydrate diet had no effect on markers of 
oxidative stress and inflammation (Petersson et al., 2010). 
The Mediterranean diet is associated with increased circulating plasma antioxidant levels and 
decreased oxidative stress (Azzini et al., 2011, Esposito et al., 2011, Yubero-Serrano et al., 2011). 
The protective properties of this diet may be derived not only from its increased antioxidant 
concentration but also through its high raw food intake, lower production of cooking-related 
oxidants and consequent decreased use of nutritional and endogenous antioxidants, and 
increased fibre intake (Ghiselli et al., 1997). Olive oil, the main source of fat in the Mediterranean 
diet, is also effective in lowering lipid peroxidation and oxidative stress (Alarcon de la Lastra et 
al., 2001, Fito et al., 2007) 
4.1.4. Diet and its effect on neuroprogression 
Diet quality is important for the brain given its capacity both to enhance neurogenic factors and 
to influence rates of neurodegeneration. In animal studies, brain levels of BDNF decreased in rats 
maintained on a high carbohydrate diet (Maioli et al., 2012) and high fat diet (Yamada-Goto et al., 
2012). Human trials have also demonstrated a relationship between diet and BDNF. Compared to 
a low-fat diet, adherence to a Mediterranean diet was associated with an improvement in plasma 
BDNF concentration in individuals with depression (Sanchez-Villegas et al., 2011). In healthy 
adults, a high-fat meal decreased plasma BDNF by almost 30% (Karczewska-Kupczewska et al., 
2011). The importance of diet on neuroprogression is further confirmed by a study on insulin-
resistant, overweight and obese subjects where serum BDNF levels increased after three months 
on a reduced calorie diet (Araya et al., 2008).   
 
Investigations into the potential effects of ω-3 PUFAs have revealed that they may also play a role 
in neuroprogression. In animal studies, ω-3 PUFAs supplementation provided protection against 
reduced plasticity and normalised BDNF after traumatic brain injury (Wu et al., 2004). During 
pregnancy and lactation, supplementation with ω-3 PUFAs protected levels of BDNF and nerve 
growth factor (NGF) in female rats when they consumed a micronutrient-imbalanced diet (Sable 
et al., 2012), while brain levels of BDNF decreased during diets deficient in ω-3 PUFAs (Bhatia et 
al., 2011, Rao et al., 2007). In an human open-label trial, 3 months of ω-3 PUFAs supplementation 
increased serum BDNF levels and prevented posttraumatic distress after accidental injury in 
patients presenting at an intensive care unit (Matsuoka et al., 2011). However, in a randomised, 
double-blind, placebo-controlled study of diabetic patients with major depression, 12 weeks of 
ethyl-EPA supplementation or placebo, in addition to ongoing antidepressant therapy, failed to 
increase serum BDNF levels (Bot et al., 2011). 
4.1.5. Diet and its effect on the HPA axis 
Diet composition and timing have a significant influence on acute cortisol secretion due to the 
primary role of cortisol in gluconeogenesis.  However, the long-term effect of diet on HPA 
activity is not well understood. In a study on women living in a Mediterranean area, a disturbed 
HPA axis was associated with a higher content of fat and saturated fatty acids in the diet. In 
contrast, adherence to a dietary pattern closer to the Mediterranean diet was linked with smaller 
HPA axis disturbances (Garcia-Prieto et al., 2007). Investigations into the effect of ω-3 PUFAs on 
HPA activity have also provided some evidence of their capacity to lower cortisol activity. For 
example, Delarue et al. (2003) showed that after 3 weeks on a diet supplemented with ω-3 
PUFAs, levels of plasma noradrenaline and cortisol stimulated by mental stress were 
significantly blunted. In another study on patients with major depression, serum cortisol levels 
decreased after 8 weeks of treatment with EPA alone or in combination with fluoxetine (Jazayeri 
et al., 2010). Finally, intravenous lipopolysaccharide-induced adrenocorticotropic hormone 
(ACTH) and cortisol plasma levels decreased significantly in healthy subjects supplemented with 
one month of fish oil compared to placebo (Michaeli et al., 2007).  
4.1.6. Diet and its effect on mitochondria 
Mitochondrial dysfunction is influenced significantly by nutrition (Civitarese et al., 2007, Hepple, 
2009, Page et al., 2010, Vitetta and Anton, 2007). Increased fatty acid exposure, resulting from 
high fat diets or overfeeding, is linked both with decreased mitochondrial number and markers 
of oxidative phosphorylation. Conversely, caloric restriction can stimulate mitochondrial 
biogenesis by elevating the transcriptional processes that regulate mitochondrial mass, improve 
mitochondrial efficiency, activate ROS scavenging mechanisms, and lower ROS production 
(Civitarese et al., 2007). Dietary antioxidants or caloric restriction, as well as chemical 
antioxidants, can lower mitochondrial ROS production (Vitetta and Anton, 2007). Nutrients such 
as CoQ10, vitamin B2 and l-carnitine also have a significant influence on mitochondrial 
metabolism (Gardner and Boles, 2011). 
4.2. The relationship between sleep and depression 
In the general population approximately 30% of people report symptoms of insomnia, 10 to 20% 
describe dissatisfaction with sleep, and approximately 6% have a formal diagnosis of insomnia 
(Leger et al., 2000, Ohayon, 2002). These rates are significantly increased in major depression, 
with as high as 90% of patients reporting sleep disturbances (Motivala et al., 2006, Riemann and  
 
Voderholzer, 2003). Insomnia is also one of the most common prodromal features of depression 
with sleep symptoms preceding an episode of depression in 40% of cases. A history of persistent 
insomnia is also associated with a significantly increased risk of developing a new depressive 
episode (Taylor et al., 2005). In a recent meta-analysis, compared to people with no sleep 
difficulties, non-depressed people with insomnia were predicted to have a twofold increased risk 
of developing depression (Baglioni et al., 2011). Depressed patients suffering from insomnia also 
have a poorer response to treatment and are at increased risk of relapse (Dombrovski et al., 2008).  
Further support for a relationship between sleep and depression is provided by studies 
documenting improvements in mood and depressive symptoms following insomnia-specific 
interventions. For example, in a randomised controlled study, Manber and colleagues (2008) 
found that augmenting antidepressant medication with a symptom-focused cognitive-
behavioural therapy for insomnia (CBTI) enhanced treatment outcomes in participants with co-
morbid major depression and insomnia. Compared to participants allocated to control treatment, 
people receiving CBTI experienced significantly greater remission rates in both depression (61.5% 
vs 33.3%) and insomnia (50% vs 7.7%). In women with insomnia and breast cancer, CBTI was also 
more effective in improving sleep, depression and anxiety symptoms than a control condition 
(Savard et al., 2005). Eight weeks of mindfulness-based cognitive therapy for treating insomnia 
symptoms also improved sleep, anxiety and depressive symptoms in patients with an anxiety 
disorder (Yook et al., 2008). 
4.2.1. Sleep and its effect on inflammation 
Sleep difficulties increase inflammatory mediators; conversely elevated inflammatory molecules 
heighten the risk of sleep problems. In particular, IL-1, IL-6 and TNF-α may be directly involved 
in sleep regulation (Santos et al., 2007). Data derived from electrophysiological, biochemical and 
molecular genetic studies demonstrate that these cytokines are sleep regulatory, as they support 
the regulation of spontaneous sleep-wake behaviour (Opp, 2005). Other cytokines that may also 
be involved in the regulation of sleep include IL-2, IL-8, IL-15, IL-18, epidermal growth factor, 
acidic fibroblast growth factor, colony stimulating factor, and interferons (Krueger, 2008).  
In patients with major depression, difficulty initiating sleep correlated with increased pre-sleep 
levels of IL-6 (Motivala et al., 2005). In a study on 210 healthy young men and women, difficulty 
falling asleep was related to higher morning levels of CRP and IL-6, but only in women (Suarez, 
2008). Sleep disturbances also occur in up to 30% of patients with chronic hepatitis C undergoing 
IFN-α therapy (Sockalingam et al., 2010), and its administration reduces sleep continuity and 
depth and induces a sleep pattern consistent with insomnia and hyperarousal (Raison et al., 
2010b). Studies on patients diagnosed with primary insomnia offer additional evidence for the 
relationship between sleep and inflammation, as circulating levels of IL-6 and TNF are higher 
than in healthy sleepers (Burgos et al., 2006, Vgontzas et al., 2002).  
Sleep restriction studies in animals and humans provide further confirmation for the association 
between sleep and inflammation. Although the relationship is not necessarily linear, there is 
evidence that in humans, sleep restriction increases levels of IL-6, TNF-α, CRP and IL-1β  
(Motivala, 2011, van Leeuwen et al., 2009, Vgontzas et al., 1999, Vgontzas et al., 2004). Five days 
of sleep deprivation in healthy adults also modified a number of kynurenine pathway 
metabolites in healthy adults, including 5-hydroxyindoleacetic acid (5-HIAA), xanthurenic acid 
and anthranilic acid (Kuhn et al., 1968).  
 
4.2.2. Sleep and its effect on neurotransmitters 
Surprisingly little research on the influence of sleep on monoamines such as serotonin and 
dopamine has been conducted, although sleep restriction may disrupt systems associated with 
monoamine communication. In an animal study, desensitisation in serotonin receptors was 
detected after eight days of sleep restriction. Despite unlimited recovery sleep, this 
desensitisation persisted for at least seven days (Roman et al., 2005b), and was independent of 
adrenal hormones (Roman et al., 2006). In addition, Novati and colleagues (2008) demonstrated 
that exposure to a schedule of chronic, partial sleep deprivation reduced sensitivity of 5HT1A 
receptors and/or receptors for CRH (Novati et al., 2008). 
4.2.3. Sleep and its effect on oxidative stress 
It has been proposed that cerebral free radicals accumulate during wakefulness and are removed 
during sleep (Reimund, 1994). This has been supported by animal studies where sleep loss 
caused oxidative damage in the brain (Ramanathan et al., 2002, Suer et al., 2011) and increased 
lipid peroxidation (Thamaraiselvi et al., 2012). However, some animal studies have found that 
one to two weeks of sleep deprivation had no effect on oxidative stress in any brain region, 
including protein oxidation and lipid peroxidation (D'Almeida et al., 1997, Gopalakrishnan et al., 
2004). These inconsistent findings are likely a reflection of differing sleep restriction protocols, 
and different markers of oxidative stress measured across studies. 
Most studies on oxidative stress in clinical sleep research have focused on obstructive sleep 
apnoea syndrome, which is known to increase oxidative stress produced by recurrent episodes of 
ischemia-reperfusion injury (Kent et al., 2011, McNicholas, 2009). However, several studies have 
also linked oxidative stress with insomnia. For example, levels of thiobarbituric acid reactive 
substances were elevated in postmenopausal women with insomnia,  although blood 
concentrations of catalase, superoxide dismutase, and glutathione were found to be normal 
(Hachul de Campos et al., 2006). In an investigation on participants with primary insomnia, 
significantly lower GSH-Px (selenium-containing antioxidant enzyme) activity and higher MDA 
levels were found compared with controls (Gulec et al., 2012). Further evidence of a relationship 
between sleep and oxidative stress is provided by a study revealing increased levels of 
myeloperoxidase-modified low-density lipoprotein following five nights of sleep restriction in 
healthy males (Boudjeltia et al., 2011). 
4.2.4. Sleep and its effect on neuroprogression 
Sleep problems may also contribute to depressive symptomatology via their effect on brain 
structure, neurogenesis and, in particular, hippocampal function (Lucassen et al., 2010, Meerlo et 
al., 2009, Novati et al., 2011). Experimental studies show that prolonged sleep restriction or 
disruption affects hippocampal integrity (Guzman-Marin et al., 2006, Kopp et al., 2006, 
McDermott et al., 2003, Roman et al., 2005a). For example, in young male rats, one month of 
chronic sleep restriction reduced dorsal hippocampal volume by 10% (Novati et al., 2011). 
Hippocampal cell proliferation was also affected by a single day of sleep deprivation in rats 
(Roman et al., 2005a). Clinical studies have also reported a reduction in hippocampal volume in 
primary insomnia and sleep apnoea (Morrell et al., 2003, Riemann et al., 2007). Insomnia severity 
in a sample of patients with post-traumatic stress disorder was also associated with decreased 
volume in the CA3/dentate hippocampal subfield (Neylan et al., 2010).   
 
While sleep restriction itself may not be neurotoxic, it may enhance neuronal sensitivity to 
subsequent excitotoxic insults. Novati and colleagues (2012) found that after 30 days of sleep 
restriction in rats, there were no adverse effects on cholinergic cells in the nucleus basalis 
magnocellularis (NBM). However, an injection of a neurotoxic dose of N-methyl-d-aspartate into 
the NBM caused an accentuated loss of cholinergic NBM cells and cortical fibres in the sleep-
restricted rats compared to controls. Thus, chronic sleep restriction may constitute a mild threat 
to the brain that does not lead to neurodegeneration by itself but increases vulnerability to 
subsequent neurotoxic challenges. 
4.2.5. Sleep and its effect on the HPA axis  
Insomnia appears to be associated with hyperarousal. In a study on patients with chronic 
insomnia, 24-hour urinary cortisol levels correlated positively with total wake time. Sleep quality 
also correlated negatively with urinary levels of catecholamine metabolites, thereby suggesting 
disturbances in both limbs of the stress system (i.e., the HPA axis and the sympathetic system) 
(Vgontzas et al., 1998). In another study, ACTH and cortisol secretions were significantly higher 
in insomniacs compared with normal controls, with greatest elevations in the evening and first 
half of the night. Cortisol levels were also positively correlated with the severity of reported sleep 
disturbance (Vgontzas et al., 2001). Increased evening and nocturnal plasma cortisol 
concentrations were also observed in patients with primary insomnia, with a strong positive 
correlation between evening cortisol secretion and the number of nocturnal awakenings both in 
insomniac patients and controls (Rodenbeck and Hajak, 2001).  
Findings in sleep deprivation and restriction studies are less consistent, with several studies 
reporting mild elevations of cortisol (Leproult et al., 1997, Spiegel et al., 1999) while others have 
found no change or even slightly decreased levels (Follenius et al., 1992, Kant et al., 1984). In 
several animal studies, sleep deprivation led to mild activations of the HPA axis and elevated 
plasma levels of glucocorticoids (Meerlo et al., 2002, Suchecki et al., 1998), whereas others found 
little or no effect of acute sleep deprivation on glucocorticoid levels (Rechtschaffen et al., 1983). 
According to Meerlo et al. (2008) the available data from studies in laboratory animals suggest 
that sleep restriction may gradually change certain brain and neuroendocrine systems in a 
manner similar to that seen in stress-related disorders such as depression.  
4.2.6. Sleep and its effect on mitochondria 
Because of the important role of sleep on oxidative stress, it would seem logical to assume that 
mitochondria will be adversely affected by sleep deprivation. In support of this, sleep 
deprivation in mice reduced the activity of the complex I, II and III enzymes of the mitochondrial 
electron transport chain. Complex II and II-III activity was particularly decreased in the 
hypothalamus of mice during 24-hour recovery sleep (Andreazza et al., 2010). In a model 
developed by Andreazza et al. (2010), it was proposed that sleep restriction may lead to 
mitochondrial dysfunction which, in turn, increases the production of ROS, leading to increased 
oxidative damage to lipids, protein and DNA.   
4.3. The relationship between exercise & depression 
Depression is commonly associated with low levels of physical activity. While data derived from 
epidemiological and correlational studies do not necessarily confirm causation, a consistent 
relationship does exist across a number of populations. In adults, an active lifestyle was  
 
associated with reduced depressive symptoms independent of education and physical health 
status. This relationship was stronger in women and those aged 40 years and older (Stephens, 
1988). In overweight/obese adults, a reduced risk of depression was associated with increasing 
moderate-to-vigorous-intensity physical activity and decreasing sedentary time (Vallance et al., 
2011). Another study on data from over 4,000 men and women aged 20 years or more confirmed 
that adults with depression spent significantly less time both in light and moderate physical 
activity than non-depressed adults (Song et al., 2012). In a longitudinal study of over 9,000 
people, regular physical activity was associated with a reduced likelihood of depressive 
symptoms at follow-up (Azevedo Da Silva et al., 2012).  
Although not as extensive, investigations into sedentary behaviours have also largely confirmed 
a positive relationship with depression. In a systematic review of seven observational and four 
intervention studies on adult populations, Teychenne and colleagues (2010) confirmed that, on 
balance, sedentary behaviours such as watching television or using the computer were associated 
with an increased risk of depression. However, evidence was limited by methodological 
weaknesses in most studies.  
The efficacy of exercise as a treatment for depression is summarised in over a dozen recent 
reviews. In a meta-analysis on supervised and unsupervised physical activity interventions 
among healthy adults, Conn (2010) concluded that physical activity interventions had a moderate 
inhibitory effect on depressive symptoms in adults with and without clinical depression (mean 
effect size of 0.37 for supervised and 0.52 for unsupervised physical activity studies). Carek and 
colleagues (2011) maintained from a review of the literature that exercise compared favourably to 
antidepressant medications as a first-line treatment for mild-to-moderate depression and also 
improved depressive symptoms when used as an adjunct to medications. Similar antidepressant 
effects were also found in trials comparing exercise with cognitive-behavioural therapy (Rimer et 
al., 2012). Despite these positive findings there is a paucity of research demonstrating long-term 
beneficial effects of exercise in patients with clinical depression (Krogh et al., 2011). 
4.3.1. Exercise and its effect on inflammation 
Although a single bout of exercise provokes an acute inflammatory response, primarily in IL-6 
(release from muscle increases up to 100-fold during contractile exercise), exercise is followed by 
an increase in anti-inflammatory cytokines (Pedersen and Fischer, 2007)  and a decreased 
production of the pro-inflammatory cytokines TNF-α and IL-1β (Pedersen et al., 2003). Data also 
suggest that exercise-induced IL-6 inhibits TNF-α production in the presence of low-grade 
inflammation (Starkie et al., 2003).  
Four recent reviews have primarily revealed anti-inflammatory effects from long-term exercise 
(Beavers et al., 2010, Mathur and Pedersen, 2008, Ploeger et al., 2009, Thomas and Williams, 
2008). In a systematic review of 19 studies on the inflammatory effects of acute and chronic 
exercise in children and adults, Ploeger et al. (2009) concluded that training programs can 
attenuate chronic inflammation in some patients with chronic inflammatory disease; however, 
the exercise training-induced response appeared highly dependent on the type of disease, 
severity of the disease and the frequency, duration and intensity of the exercise intervention.  
Lower inflammatory biomarker concentrations, particularly CRP, and to a lesser extent IL-6, are 
observed across a wide range of individuals performing more frequent and intense physical 
activity (Plaisance and Grandjean, 2006, Taaffe et al., 2000). This inverse relationship between 
CRP and physical activity is consistently seen in men, and to a lesser extent in women (Beavers et  
 
al., 2010). In adults, investigations using self-reported measures of physical activity have 
demonstrated that physically-active individuals have CRP concentrations 19–35% lower than less 
active individuals (Plaisance and Grandjean, 2006).  While these inflammatory markers are 
attenuated following adjustment for adiposity, a significant relationship between inflammatory 
biomarkers and physical activity persists (Abramson and Vaccarino, 2002).  
In sum, while most studies demonstrate anti-inflammatory effects of exercise in adults and 
children, the relationship is influenced by a number of factors including the population studied, 
the type, frequency and duration of exercise, pre-existing medical conditions and initial levels of 
inflammation. Thus, further studies are required to enable more definitive conclusions, 
particularly in patients suffering from depression. 
4.3.2. Exercise and its effect on neurotransmitters 
The antidepressant effects of exercise may be due to its capacity to modify monoamine 
communication.  In animal studies, running increased plasma free tryptophan, brain tryptophan, 
and levels of the serotonin metabolite, 5-HIAA (Bailey et al., 1993, Chaouloff et al., 1985). Human 
trials also provide evidence of exercise and its serotonin-enhancing effects. For example, 
untrained participants randomly assigned to an aerobic exercise group experienced greater 
changes in serum serotonin levels compared to those in a stretching-control group (Wipfli et al., 
2011). Tryptophan availability, the precursor to serotonin, is also increased after acute exercise 
(Melancon et al., 2012). Three weeks of exercise training also influenced serotonin receptors and 
serotonin transporters in sedentary males as demonstrated by increased levels of 5-HT 
transporters (5-HTT) and 5-HT2A receptors on isolated platelet membranes. In contrast, four 
weeks of excessive training in well-trained athletes did not change 5-HTT, and 5-HT2A receptor 
density declined. This suggests that the impact of exercise on serotonin neurotransmission may 
depend on the training state of athletes and extent of exertion (Weicker and Struder, 2001). 
Exercise is also able to modify dopamine and noradrenergic transmission as evidenced by 
increased tyrosine hydroxylase expression (Foley and Fleshner, 2008, Kim et al., 2011), elevated 
striatal dopamine D2 receptor expression (Vuckovic et al., 2010) and increased noradrenaline 
levels (Dishman, 1997) in rats exposed to chronic exercise. However, acute exercise comprising 30 
minutes of vigorous exercise in healthy adult volunteers with a history of regular exercise did not 
change synaptic dopamine concentrations (Wang et al., 2000). 
4.3.3. Exercise and its effect on oxidative stress 
There is mounting evidence to suggest that exercise is accompanied by an increased generation of 
free radicals, resulting in measurable elevations in oxidative stress biomarkers after both acute 
aerobic (Benitez-Sillero et al., 2011, Bloomer, 2008, Fogarty et al., 2011) and anaerobic exercise 
(Bloomer and Goldfarb, 2004, Pittaluga et al., 2006, Vollaard et al., 2005). Given the substantial 
evidence for the protective effects of exercise on oxidative stress-associated diseases, this seems 
paradoxical. However, it is argued that chronic exercise leads to exercise-induced adaptation and 
resistance (Cooper et al., 2002, Radak et al., 2008). The exercise-induced ROS formation evokes 
specific adaptation, comprising up-regulation in endogenous antioxidant defences, increased 
antioxidant/oxidative damage-repairing enzyme activity, increased resistance to oxidative stress, 
and lowered levels of oxidative damage. This adaptive response seems to be systemic, affecting 
skeletal muscle, liver, and the brain (Radak et al., 2008). Gomez-Cabrera et al (2008) argue that 
because exercise results in an up-regulation of powerful antioxidant enzymes, exercise itself can 
be considered an antioxidant despite generating free radicals.   
 
4.3.4. Exercise and its effect on the HPA axis 
The relationship between exercise and HPA activity is complex as it is influenced by duration, 
type, intensity and chronicity of exercise; characteristics of the stressor used; and characteristics 
of the population studied (Campeau et al., 2010, Leal-Cerro et al., 2003, Mastorakos et al., 2005, 
Stranahan et al., 2008).  In an animal study, four weeks of swimming exercise was associated with 
reduced levels of serum corticosterone and depressive behaviours in rats exposed to high levels 
of glucocorticoids prenatally (Liu et al., 2012a). In another study, the HPA axis response to lower-
intensity stressors decreased in rats exposed to 6 weeks (but not 1 or 3 weeks) of intermittent, 
voluntary wheel running, although no change occurred following exposure to more intense 
stressors (Campeau et al., 2010).  The complexity of the relationship between exercise and HPA 
responsivity was further demonstrated by Droste et al. (2003) who reported that HPA responses 
in exercising mice were differently influenced by the stressor used and the novelty of the 
environment.  
Investigations into the relationship between exercise and HPA activity in human populations 
have primarily examined the effect of acute activity on measures such as cortisol and ACTH. 
Studies on the influence of chronic exercise on HPA activity, and in particular on the HPA 
response to stressors, are sparse. In general, acute exercise elevates cortisol levels, although this 
most consistently occurs following moderate-to-severe intensity activity (Hill et al., 2008). In a 
study on women of varying age and fitness, ACTH levels recovered slowly in older women, 
particularly those with low fitness levels (Traustadottir et al., 2004). In a study on female 
adolescents with mild-to-moderate depression, 8 weeks of an exercise regimen improved 
depressive symptoms and was associated with reductions in 24 hour urinary cortisol levels 
(Nabkasorn et al., 2006). In another study on patients with chronic low back pain, twelve weeks 
of high-intensity aerobic exercise was associated with reductions in pain, enhanced mood and 
improvements in HPA responsiveness to the dexamethasone suppression test (Chatzitheodorou 
et al., 2008).   
4.3.5. Exercise and its effect on neuroprogression 
Evidence of the beneficial effects of exercise on brain function is summarised in three recent 
reviews (Cotman et al., 2007, Dishman et al., 2006, Vivar et al., 2012). Exercise is associated with 
enhanced adult hippocampal neurogenesis and increased activity-dependent synaptic plasticity. 
According to Cotman et al. (2007), enhanced hippocampal neurogenesis and increased synaptic 
plasticity are the most reproducible effects of exercise in the rodent brain. In both young and old 
animals, exercise stimulated neural progenitor populations, increased the number of new 
neurons, and promoted survival of these new cells (Brandt et al., 2010, Olson et al., 2006, Wu et 
al., 2008). In animal studies, exercise also increased BDNF in several brain regions, and there was 
increased insulin-like growth factor-1 (IGF-1) gene expression and peripheral circulating levels of 
IGF-1 (Ding et al., 2006, Schwarz et al., 1996). In a review on the effects of exercise on peripheral 
BDNF in human subjects, it was concluded that exercise temporarily elevated basal BDNF and 
possibly up-regulated BDNF cellular processing (i.e. synthesis, release, absorption and 
degradation) (Knaepen et al., 2010). However, there have been no reported findings of long-
lasting BDNF responses to acute exercise or training. 
Human studies on the effects of exercise-induced BDNF changes in depressed populations are 
still preliminary, although BDNF levels were transiently increased in elderly women with  
 
remitted major depression (Laske et al., 2010) and in unmedicated patients suffering from major 
depressive disorder (Gustafsson et al., 2009).  
4.3.6. Exercise and its effect on mitochondria 
An accumulating body of literature has demonstrated that endurance exercise effectively 
stimulates mitochondrial biogenesis in a wide range of tissues including skeletal muscle, adipose 
tissue, liver, brain, and kidney (Little et al., 2011). Vina et al. (2009) concluded that exercise, and 
particularly aerobic exercise, activated mitochondriogenesis in young animals, although its 
influence on older animals required further investigation. Eight weeks of treadmill training in a 
murine model augmented mitochondrial function, as reflected by increased mitochondrial 
enzyme activities, maximal rate of ATP synthesis in isolated mitochondria, and whole-body 
maximal O2 uptake (Chow et al., 2007). Lanza et al. (2009) reviewed a number of studies which 
demonstrated that older adults enrolled in exercise training programs respond with increased 
VO2 peak, mitochondrial content, oxidative enzyme activities, muscle protein synthesis rates, 
mitochondrial protein gene transcripts, and mitochondrial DNA copy number. 
5. Conclusion and directions for future research 
While the importance of lifestyle factors such as diet, exercise and sleep are generally 
acknowledged in the research literature on major depression, the mechanisms of their potential 
influence are often not fully appreciated. As illustrated in figure 3, diet, exercise and sleep can 
influence several physiological pathways associated with depression. A bi-directional 
relationship likely exists between depression and these lifestyle factors, thereby creating a 
potentially increasing cycle of influence. Key symptoms of major depression include changes in 
appetite, sleep, energy and general motivation levels; all likely to have significant effects on diet, 
exercise and obviously sleep patterns. The importance of these lifestyle factors was highlighted in 
a recent paper by Jacka et al (2012) who argued that depression should be included under the 
umbrella of non-communicable diseases influenced by lifestyle factors, with increasing efforts 
directed toward prevention through the promotion of lifestyle changes.   
 
<<<insert Figure 3 near here> 
 
While these lifestyle factors are significant in the etiology and maintenance of depression, a 
multitude of other lifestyle influences may also be important. These include chronic stress, social 
influences, mental and physical effects associated with medical diseases, alcohol and other drug 
use, chronic pain and even exposure to sunlight/vitamin D. It is these influences, plus a large 
array of psychological, genetic and biological factors that often make the treatment of depression 
difficult. Basic interventions comprising attention towards one cause and/or one biochemical 
mechanism (e.g., targeting a single neurotransmitter disturbance) makes the goal of remission or 
recovery less likely. This was highlighted in a recent study where giving simple written 
recommendations about lifestyle changes for sleep hygiene, physical activity, diet, and sunlight 
exposure enhanced outcomes to standard antidepressant treatment (Garcia-Toro et al., 2012). 
Remission/response rates reached 60% in the combined treatment group compared with only 
10% in the anti-depressant only group.  
 
Future research needs to be directed toward better understanding the role that diet, exercise, 
sleep and other lifestyle factors play in depression and other mental health conditions. While this 
review provides a comprehensive coverage of the research literature, with a specific emphasis on 
the biological effects of these lifestyle factors on depression, a future more systematic review with 
well-defined search strategies and inclusion criteria would be beneficial to further elucidate the 
role these lifestyle factors play in depression, particularly those addressing diet.  
A limitation associated with many of the studies reviewed is that significant portions were 
correlational and/or epidemiological, thereby limiting conclusions about causation. Other 
influences such as general healthy lifestyle behaviours, socioeconomic status and medical 
illnesses are examples of confounding factors that may have influenced findings in some studies. 
Given these and other confounding influences, a significant barrier associated with studies on 
dietary intervention is being able to accurately provide direct evidence that dietary change causes 
improvements in mental health. Increasing attention toward randomised, placebo-controlled 
treatment studies may help to elucidate the mediating roles that these lifestyle factors play in 
major depression. A paucity of treatment studies has investigated dietary interventions in 
depressed populations; however, an inherent problem relates to identifying methods to blind 
such interventions for participants and investigators. While this may be possible with single 
nutrients or foods, it is likely that the benefits of diet are derived from consuming a range of 
complementary foods, particularly those characteristic of Mediterranean diets (Ghiselli et al., 
1997, Milaneschi et al., 2011).  It is also important that increasing attention be given to measuring 
changes in important biomarkers associated with inflammation, oxidative stress, HPA regulation, 
neuroprogression, monoamine and mitochondrial function. Measuring changes in biomarkers 
and assessing their relationship with affective and behavioural changes should provide a greater 
understanding of mechanisms of action associated with depression. 
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Figure 1. Multiple pathways associated with major depression 
 
 
 
 
 
Figure 2. Kynurenine pathway and its metabolites. 
The kynurenine pathway starts with the degradation of tryptophan by the enzyme, indoleamine 
2,3-dioxygenase (IDO) which is upregulated by pro-inflammatory cytokines (e.g. IFN-γ, TNF-α, 
IL-, IL-6). These TRYCATS (tryptophan catabolites along the IDO pathway) have neuroprotective 
and neurotoxic effects on the CNS and influence monoaminergic transmission. 
 
  
 
 
 
 
Figure 3. Potential mechanisms of diet, sleep and exercise on major depression. 
Diet, sleep and exercise are associated with depression. These lifestyle factors influence a number 
of biological processes associated with major depression including neurotransmitter 
transmission, immuno-inflammation, oxidative and nitrosative stress, HPA balance, 
neuroprogression and mitochondrial health. Suffering from depression is also likely to lead to 
changes in diet, sleep and exercise, creating a vicious cycle of change. 
 